awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38222270-63752A0D-17E4-4D2B-ABB9-5CEF710302A3
Q38222270-63752A0D-17E4-4D2B-ABB9-5CEF710302A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222270-63752A0D-17E4-4D2B-ABB9-5CEF710302A3
Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
P2860
Q38222270-63752A0D-17E4-4D2B-ABB9-5CEF710302A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222270-63752A0D-17E4-4D2B-ABB9-5CEF710302A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
797bd84c516b44eefae73d85aaa222280bffad3d
P2860
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.